Pentamidine [1,5- bis(4-amidinophenoxy)pentane] is the exemplar of a growing class of dicationic, aromatic agents active against a variety of infectious agents of significance to immunocompromised and normal individuals. Pentamidine is still an important """"""""second line"""""""" agent in the prevention and treatment of Pneumocystis carinii infection predominant in AIDS patients. New dicationic molecules have shown reduced toxicity and broadened specificity against important fungal and protozoal pathogens. For example, DAP-092 (2,7 diamidinocarbazole dihydrochloride) is a highly promising agent against Cryptosporidium parvum (which causes diarrheal disease in normal and immunocompromised individuals) soon to go into clinical trials. Pentamidine, (although in use for over 50 years), is hampered by its toxicity and narrow therapeutic range. Measurement of pentamidine in biological samples is difficult relying on HPLC (sometimes supplemented by mass spectroscopy) and other physical methods. Recently, we have developed a facile immunoassay for pentamidine which shows promise in monitoring patient drug levels and also as a model for immunoassays for new cationic drugs. Hence, the overall goal of this proposal is to develop a practical clinical assay for a dicationic drug (pentamidine) and extend this model to a new agents (such as DAP-092) for use in preclinical and clinical trials.

Proposed Commercial Applications

Proposed Commercial Applications

not available.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41AI042460-01
Application #
2538240
Study Section
Special Emphasis Panel (ZRG2-SSS-4 (02))
Project Start
1998-02-01
Project End
1999-01-31
Budget Start
1998-02-01
Budget End
1999-01-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Immtech International, Inc.
Department
Type
DUNS #
City
Vernon Hills
State
IL
Country
United States
Zip Code
60061
Sawalha, Amr H; Schmid, Wendi R; Binder, Steven R et al. (2004) Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 31:1546-50
Sawalha, Amr H; Potts, Robyn; Schmid, Wendi R et al. (2003) The genetics of primary Sjogren's syndrome. Curr Rheumatol Rep 5:324-32
Quintero-Del-Rio, A I; Kelly, J A; Kilpatrick, J et al. (2002) The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 3 Suppl 1:S57-62
Reisner, H M; Gray, D R; Jones, S K et al. (2000) Immunoassays for pentamidine and related compounds: development of a facile inhibitory ELISA suitable for clinical use. J Clin Lab Anal 14:73-82